Skip to main content
. 2023 Mar 22;28(8):682–690. doi: 10.1093/oncolo/oyad035

Figure 2.

Figure 2.

PTEN mutation as predictor of post-CDKi disease progression. (A) Frequency of mutations among subset of 37 patients with available clinical NGS prior to CDKi initiation. All but 4 of these patients had >1 mutation (of the 12 genes we analyzed). (B) Post-CDKi PFS Kaplan-Meier curves by pre-CDKi PTEN mutational status.